Stem definition | Drug id | CAS RN |
---|---|---|
2487 | 110-15-6 |
None
None
None
None
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:49201 | anti-ulcer drug |
CHEBI has role | CHEBI:50733 | nutraceutical |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Iron deficiency anemia | indication | 87522002 | |
Peptic ulcer | contraindication | 13200003 | DOID:750 |
Primary hyperoxaluria | contraindication | 17901006 | DOID:2977 |
Gastroenteritis | contraindication | 25374005 | DOID:2326 |
Hemosiderosis | contraindication | 39011001 | DOID:12119 |
Hemolytic anemia | contraindication | 61261009 | DOID:583 |
Ulcerative colitis | contraindication | 64766004 | DOID:8577 |
Anemia due to enzyme deficiency | contraindication | 111577008 | |
Hb SS disease | contraindication | 127040003 | DOID:10923 |
Diverticular disease | contraindication | 397881000 | |
Hemochromatosis | contraindication | 399187006 | DOID:2352 |
Repeated Blood Transfusions | contraindication |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 3.81 | acidic |
pKa2 | 5.28 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Egl nine homolog 1 | Enzyme | IC50 | 5.52 | CHEMBL | |||||
Succinate receptor 1 | GPCR | AGONIST | EC50 | 4.70 | IUPHAR |
ID | Source |
---|---|
4028568 | VUID |
N0000178335 | NUI |
C0075429 | UMLSCUI |
60376006 | SNOMEDCT_US |
NOCODE | MMSL |
4028568 | VANDF |
37255 | RXNORM |
002404 | NDDF |
AB6MNQ6J6L | UNII |
1110 | PUBCHEM_CID |
CHEBI:15741 | CHEBI |
CHEMBL576 | ChEMBL_ID |
DB00139 | DRUGBANK_ID |
SIN | PDB_CHEM_ID |
D019802 | MESH_DESCRIPTOR_UI |
3637 | IUPHAR_LIGAND_ID |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
IROSPAN 24/6 | HUMAN PRESCRIPTION DRUG LABEL | 20 | 50967-126 | KIT | 150 mg | None | unapproved drug other | 9 sections |
Viatrexx-Adipose | HUMAN PRESCRIPTION DRUG LABEL | 10 | 73069-024 | INJECTION | 31 [kp_C] | INTRAVENOUS | unapproved drug other | 11 sections |
Viatrexx-Cellulite | HUMAN PRESCRIPTION DRUG LABEL | 10 | 73069-081 | INJECTION | 31 [kp_C] | INTRAVENOUS | unapproved drug other | 11 sections |
Viatrexx-Facial | HUMAN PRESCRIPTION DRUG LABEL | 11 | 73069-164 | INJECTION | 31 [kp_C] | INTRAVENOUS | unapproved drug other | 11 sections |
Viatrexx-Ki-UB | HUMAN PRESCRIPTION DRUG LABEL | 2 | 73069-277 | INJECTION | 31 [kp_C] | INTRAVENOUS | unapproved drug other | 11 sections |
Viatrexx-Pigmentation | HUMAN PRESCRIPTION DRUG LABEL | 9 | 73069-410 | INJECTION | 31 [kp_C] | INTRAVENOUS | unapproved drug other | 11 sections |
Niferex | HUMAN PRESCRIPTION DRUG LABEL | 5 | 75854-321 | TABLET | 50 mg | ORAL | unapproved drug other | 12 sections |